AHA Scientific Sessions 2026 Abstract
Amputations differ by drug in type 2 diabetes with leg artery disease
Among adults with type 2 diabetes and leg artery disease, one-year minor amputation rates were 1.0% for drugs such as semaglutide versus 1.6% for drugs such as…Among adults with type 2 diabetes and leg artery disease, one-year minor amputation rates were 1.0% for drugs such as semaglutide versus 1.6% for drugs such as empagliflozin.

Cohort studyType 2 diabetes
Who was studiedAdults with type 2 diabetes and PAD, 5 years, against SGLT2 inhibitor users
What changedMinor amputations at one year were 1.0% with drugs such as semaglutide versus 1.6% with drugs such as empagliflozin
The catchDifferences in leg disease severity or prescribing choices could have affected amputation risks

